ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shafi, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shafi, N.
Annals of Clinical and Laboratory Science, Vol 16, Issue 5, 365-372
Copyright © 1986 by Association of Clinical Scientists


Articles

Evaluation of the platelet surface by fluorescence flow cytometry

NQ Shafi

Flow cytometry has significantly contributed to cell biology, especially with use of tagged monoclonal antibodies. Discovery of specific platelet surface membrane receptors has helped to elucidate the pathogenesis of several platelet related disorders. Concomitantly, monoclonal antibodies to specific receptors have also been developed. Using fluorescent antibody techniques, small populations of platelets with distinct characteristics can be analyzed efficiently. Monoclonal antibodies, e.g., (AP-3), specific for glycoprotein, IIIa and (6DI), directed against an epitope close to the VWF binding site, have already been employed,--the latter by fluorescence flow cytometry. In addition to studies of primary surface membrane disorders, flow cytometry has been applied to measurements of surface immunoglobulin and C3 on individual platelets in autoimmune and alloimmune thrombocytopenia. Flow cytometry may also be utilized for platelet crossmatching. This simple, specific and non-radioactive technique can effectively provide accurate platelet surface data in a small clinical laboratory.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1986 by the Association of Clinical Scientists.